Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 4565

Max Ratio

Dividend Yield

0.30 %

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History 4565

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.30 %
Consecutive Years 0
Forward Annual Dividend 2.50 JPY
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 03/27/2015

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 4565

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 4565

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 4565

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 4565

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 4565

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Nxera Pharma Co., Ltd. 4565

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 4565

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.46
Price Sales TTM 2.58
Enterprise Value EBITDA 126.33
Price Book MRQ 1.12

Nxera Pharma Co., Ltd. Dividends: – Yield, History, Payment Schedule

4565
Current price
838.00 JPY +16.02 JPY (+1.95%)
Last closed 819.00 JPY
ISIN JP3431300007
Sector Healthcare
Industry Biotechnology
Exchange Tokyo Stock Exchange
Capitalization 74 186 465 516 JPY
Yield for 12 month -22.48 %
1Y
3Y
5Y
10Y
15Y
4565
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+28 862 718 722 JPY

Last Year

+12 778 271 746 JPY

Current Quarter

+8 458 122 861 JPY

Last Quarter

+6 650 386 736 JPY

Current Year

+21 239 397 541 JPY

Last Year

+9 673 289 953 JPY

Current Quarter

+6 598 336 873 JPY

Last Quarter

+5 033 834 320 JPY
EBITDA -4 202 035 573 JPY
Operating Margin TTM -46.65 %
Price to Earnings
Return On Assets TTM -3.58 %
PEG Ratio
Return On Equity TTM -9.21 %
Wall Street Target Price 296 183.68 JPY
Revenue TTM 28 727 589 247 JPY
Book Value 726.22 JPY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -27.10 %
Dividend Yield 0.30 %
Gross Profit TTM 20 446 636 056 JPY
Earnings per share -36.27 JPY
Diluted Eps TTM -36.27 JPY
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 27.00 %
Profit Margin -21.41 %

Technical Indicators 4565

For 52 Weeks

668.64 JPY 1 153.11 JPY
50 Day MA 916.52 JPY
Shares Short Prior Month
200 Day MA 895.68 JPY
Short Ratio
Shares Short
Short Percent